Literature DB >> 3090056

Development of a neural phenotype in differentiating ganglion cell-derived human neuroblastoma cells.

I G Scott, K E Akerman, J E Heikkilä, K Kaila, L C Andersson.   

Abstract

Human neuroblastoma cells (clone SHSY-5Y) induced to differentiate by 12-O-tetradecanoylphorbol-13-acetate (TPA) are shown to possess properties characteristic of mature ganglion cells. Elevation of the external K+ concentration, exposure to Ca2+ ionophore A23187, and acetylcholine all stimulate the release of preloaded 3H-noradrenaline in the presence but not in the absence of added Ca2+. Acetylcholine causes a fall in the 86Rb+ or 14C-TPMP equilibrium potential across the plasma membrane and stimulates 86Rb+ efflux. These responses are prevented by atropine. Acetylcholine and muscarine but not nicotine stimulate an increase in 45Ca2+ influx, an effect blocked by atropine. None of these responses have been observed in nondifferentiating cells. Muscarinic receptors, however, as measured by the binding of tritiated quinuclidinyl benzilate (3H-QNB), were present to a similar extent in control and differentiated cells. Both cell types also exhibit an accelerated release of Ca2+ in response to acetylcholine, but the control cells were at least 1 order of magnitude more sensitive to the agonist.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3090056     DOI: 10.1002/jcp.1041280221

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  11 in total

Review 1.  The regulation of neurotransmitter secretion by protein kinase C.

Authors:  P F Vaughan; J H Walker; C Peers
Journal:  Mol Neurobiol       Date:  1998-10       Impact factor: 5.590

2.  Considerations for the Use of SH-SY5Y Neuroblastoma Cells in Neurobiology.

Authors:  Jane Kovalevich; Maryline Santerre; Dianne Langford
Journal:  Methods Mol Biol       Date:  2021

3.  Characterization of two components of the N-like, high-threshold-activated calcium channel current in differentiated SH-SY5Y cells.

Authors:  E P Seward; G Henderson
Journal:  Pflugers Arch       Date:  1990-10       Impact factor: 3.657

4.  Early activation of endogenous pp60src kinase activity during neuronal differentiation of cultured human neuroblastoma cells.

Authors:  C Bjelfman; G Meyerson; C A Cartwright; K Mellström; U Hammerling; S Påhlman
Journal:  Mol Cell Biol       Date:  1990-01       Impact factor: 4.272

5.  IGF2 expression is a marker for paraganglionic/SIF cell differentiation in neuroblastoma.

Authors:  F Hedborg; R Ohlsson; B Sandstedt; L Grimelius; J C Hoehner; S Pählman
Journal:  Am J Pathol       Date:  1995-04       Impact factor: 4.307

6.  Insulin-like growth factor I shifts from promoting cell division to potentiating maturation during neuronal differentiation.

Authors:  S Påhlman; G Meyerson; E Lindgren; M Schalling; I Johansson
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-15       Impact factor: 11.205

7.  Studies on the mechanism of [3H]-noradrenaline release from SH-SY5Y cells: the role of Ca2+ and cyclic AMP.

Authors:  R Atcheson; D G Lambert; R A Hirst; D J Rowbotham
Journal:  Br J Pharmacol       Date:  1994-03       Impact factor: 8.739

8.  Considerations for the use of SH-SY5Y neuroblastoma cells in neurobiology.

Authors:  Jane Kovalevich; Dianne Langford
Journal:  Methods Mol Biol       Date:  2013

9.  Differential activity by polymorphic variants of a remote enhancer that supports galanin expression in the hypothalamus and amygdala: implications for obesity, depression and alcoholism.

Authors:  Scott Davidson; Marissa Lear; Lynne Shanley; Benjamin Hing; Amanda Baizan-Edge; Annika Herwig; John P Quinn; Gerome Breen; Peter McGuffin; Andrew Starkey; Perry Barrett; Alasdair MacKenzie
Journal:  Neuropsychopharmacology       Date:  2011-06-29       Impact factor: 7.853

Review 10.  Human neuroblastoma cell lines as models for the in vitro study of neoplastic and neuronal cell differentiation.

Authors:  E Abemayor; N Sidell
Journal:  Environ Health Perspect       Date:  1989-03       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.